Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Justin Balko PharmD, PhD

Justin M Balko PharmD, PhD

Assistant Professor of Medicine, Assistant Professor of Pathology, Microbiology and Immunology, Division of Microbial Pathogenesis, Leader of Molecular Oncology, Center for Cancer Targeted Therapies Researcher, Vanderbilt University Medical Center, Nashville, TN
Justin Balko, Pharm.D., Ph.D., is assistant professor in the Department of Medicine and Pathology, Microbiology and Immunology at Vanderbilt University Medical Center. His translational cancer research focuses on molecular therapies, oncoimmunology and bioinformatics.

Recent Contributions to PracticeUpdate:

  1. JAK2 and PD-L1 in 9p24 Amplified Breast Cancer
  2. The Immune Landscape of Residual TNBC After Neoadjuvant Chemotherapy
  3. Immunologic Correlates of Long-Term Outcomes in TNBC

Most Read This Week

Recently Updated